Omega-3: The Overlooked Evidence-Based Therapy for Heart Failure
- PMID: 35361441
- DOI: 10.1016/j.jchf.2022.02.004
Omega-3: The Overlooked Evidence-Based Therapy for Heart Failure
Keywords: clinical trial; epidemiology; heart failure; omega-3 fatty acids.
Conflict of interest statement
Funding Support and Author Disclosure Dr O’Keefe holds a major ownership interest in CardioTabs, a nutraceutical company. Dr Lavie has served as a consultant and speaker for both GOED and DSM. Dr O’Keefe has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization.JACC Heart Fail. 2022 Apr;10(4):227-234. doi: 10.1016/j.jchf.2021.12.006. Epub 2022 Mar 9. JACC Heart Fail. 2022. PMID: 35361440 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
